Centene Corp (CNC) Stock Price Today
Aura AI Summary
Key Stats
- $33.26BMarket Cap
- -Volume
- HealthSector
- $68.3452W High
- $25.2152W Low
- -Typical Hold Time
- $25.89BEnterprise Value
- -Div Yield
- -Trading Activity
Track Centene Corp (CNC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Centene Corp has traded between a low of $25.21 and a high of $68.34, highlighting its annual price range. Buy and sell Centene Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Most Recent News
Brazilian health authority receives application for Bavarian Nordic's chikungunya vaccine approval
Bavarian Nordic's partner Eurofarma has submitted an application to Brazil's health authority Anvisa for approval of the chikungunya vaccine CHIKV VLP, targeting prevention in people aged 12 and above. This marks a key step in making the vaccine avai...

Bavarian Nordic’s chikungunya vaccine submitted for approval in Brazil, targeting a major outbreak region.
Bavarian Nordic's partner Eurofarma has submitted a regulatory approval application for the chikungunya vaccine CHIKV VLP to Brazil's health agency Anvisa. This marks a key step in making the vaccine available in Brazil, which reports over half of gl...

Sleep water enhancers market to grow 11.9% CAGR, reaching $2.32B by 2030 driven by rising sleep disorder demand.
The global sleep water enhancers market is projected to grow from $1.48 billion in 2026 to $2.32 billion by 2030, with a CAGR of 11.9%. This growth is driven by increasing prevalence of sleep disorders, consumer preference for non-pill sleep aids, an...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.